Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Pharmacol Sci ; 124(3): 287-93, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24553453

RESUMO

Four transmembrane tyrosine kinases constitute the ErbB protein family: epidermal growth factor receptor (EGFR) or ErbB1, ErbB2, ErbB3, and ErbB4. In general, the structure and mechanism of the activation of these members are similar. However, significant differences in homologous desensitization are known between EGFR and ErbB4. Desensitization of ligand-occupied EGFR occurs by endocytosis, while that of ErbB4 occurs by selective cleavage at the cell surface. Because ErbB4 is abundantly expressed in neurons from fetal to adult brains, elucidation of the desensitization mechanism is important to understand neuronal development and synaptic functions. Recently, it has become clear that heterologous desensitization of EGFR and ErbB4 are induced by endocytosis and cleavage, respectively, similar to homologous desensitization. It has been reported that heterologous desensitization of EGFR is induced by serine phosphorylation of EGFR via the p38 mitogen-activated protein kinase (p38 MAP kinase) pathway in various cell lines, including alveolar epithelial cells. In contrast, the protein kinase C pathway is involved in ErbB4 cleavage. In this review, we will describe recent advances in the desensitization mechanisms of EGFR and ErbB4, mainly in alveolar epithelial cells and hypothalamic neurons, respectively.


Assuntos
Receptores ErbB/metabolismo , Animais , Linhagem Celular , Células Epiteliais/metabolismo , Receptores ErbB/genética , Flagelina/farmacologia , Hormônio Liberador de Gonadotropina/farmacologia , Hormônio Liberador de Gonadotropina/fisiologia , Humanos , Hipotálamo/citologia , Hipotálamo/metabolismo , Sistema de Sinalização das MAP Quinases/fisiologia , Neurônios/metabolismo , Fosforilação , Proteína Quinase C/fisiologia , Alvéolos Pulmonares/citologia , Alvéolos Pulmonares/metabolismo , Receptor ErbB-4 , Serina/metabolismo , Transdução de Sinais/fisiologia , Ativação Transcricional , Fator de Necrose Tumoral alfa/fisiologia
2.
Undersea Hyperb Med ; 40(4): 351-62, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23957206

RESUMO

Over the past 50 years hyperbaric oxygen (HBO2) therapy has been used in a wide variety of medical conditions, and one of them is cancer. Many clinical studies have been conducted to evaluate potential therapeutic effects of HBO2 as a part of cancer treatment. This review briefly summaries the potential role of HBO2 therapy in the treatment of malignant tumors and radiation injury of the brain. HBO2 therapy is used for the enhancement of radiosensitivity in the treatment of some cancers, including malignant brain tumors. Radiotherapy within 15 minutes following HBO2 exposure, a relatively new treatment regimen, has been studied at several institutes and has demonstrated promising clinical results for malignant gliomas of the brain. HBO2 therapy also increases sensitivity to some antineoplastic agents; non-randomized clinical trials using carboplatin-based chemotherapy combined with HBO2 show a significant advantage in survival for recurrent malignant gliomas. The possibilities of combining HBO2 therapy with radiotherapy and/or chemotherapy to overcome newly diagnosed and recurrent malignant gliomas deserve extensive clinical trials. HBO2 therapy also shows promising potential for the treatment and/or prevention of radiation injury of the brain after stereotactic radiosurgery for brain lesions. The possibilities with HBO2 to enhance the therapeutic effect of irradiation per se, and to even increase the radiation dose if there are ways to combat the side effects, should boost new scientific interest into the whole field of oncology looking for new armamentaria to fight cancer.


Assuntos
Neoplasias Encefálicas/terapia , Encéfalo/efeitos da radiação , Glioma/terapia , Oxigenoterapia Hiperbárica , Lesões por Radiação/terapia , Antineoplásicos/uso terapêutico , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/radioterapia , Carcinoma de Células Escamosas/terapia , Hipóxia Celular , Terapia Combinada/métodos , Resistencia a Medicamentos Antineoplásicos/fisiologia , Humanos , Lesões por Radiação/prevenção & controle , Tolerância a Radiação/fisiologia
3.
Chudoku Kenkyu ; 26(4): 295-9, 2013 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-24483008

RESUMO

Cyanamide is a known alcohol deterrent, and it may cause severe cyanamide-ethanol reaction if a patient consumes high amounts of alcohol during treatment. We report a rare case of cyanamide-ethanol reaction-induced shock in a 73-year-old man who was taking cyanamide for the treatment of alcohol dependence. The patient complained of acute onset of dyspnea after drinking. On arrival, he was in a state of shock. We immediately started hydration and administered 0.3 mg adrenaline by intramuscular injection. However, the patient's general condition did not improve. We could rescue him only after a high dose of adrenaline was administered by continuous intravascular injection. In general, in the treatment of cyanamide-ethanol reaction-induced shock, adrenaline or noradrenaline should be used instead of dopamine. Some cases of severe cyanamide-ethanol reactions have been recently reported in Japan. We performed a literature review and have discussed these cases in the text.


Assuntos
Dissuasores de Álcool/efeitos adversos , Consumo de Bebidas Alcoólicas/efeitos adversos , Bebidas Alcoólicas/efeitos adversos , Anafilaxia/tratamento farmacológico , Anafilaxia/etiologia , Cianamida/efeitos adversos , Epinefrina/administração & dosagem , Etanol/efeitos adversos , Idoso , Humanos , Injeções Intravenosas , Masculino , Índice de Gravidade de Doença , Resultado do Tratamento
4.
Emerg Med Australas ; 24(4): 460-2, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22862767

RESUMO

Decompression illness (DCI) develops during or after diving. Pulmonary decompression illness ('Chokes') is rarely seen because the affected individual usually dies in the water. We encountered a rare and interesting case. A 60-year-old man complained of leg pain after diving. Despite rapid transfer to a nearby hospital, advanced respiratory failure and shock had set in. He was then transferred to our hospital for hyperbaric oxygen therapy (HBOT). On account of his poor general condition, we initially treated him in the intensive care unit without HBOT, where he showed extreme hyperpermeability and a high level of serum procalcitonin (PCT; 20.24 ng/mL). Despite large-volume fluid therapy, severe intravascular dehydration and shock status remained. We assume that the injured endothelial cells induced vascular hyperpermeability and increased levels of inflammatory cytokines leading to the high serum PCT level. PCT might be a useful stress marker of endothelial damage and severity in DCI, including Chokes.


Assuntos
Doença da Descompressão/fisiopatologia , Endotélio Vascular/fisiopatologia , Transtornos Respiratórios/fisiopatologia , Calcitonina/sangue , Humanos , Oxigenoterapia Hiperbárica , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
5.
Pharmacology ; 67(3): 128-35, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12571408

RESUMO

The aim of this study was to determine whether the medicinal herbs growing in Okinawa and possessing a radical-scavenging activity would exert cardioprotective effects against ischemia-reperfusion injury using isolated perfused rat hearts. Effects of the aqueous extracts from Psidium guajava L. and Limonium wrightii at concentrations having an equipotent radical-scavenging activity on myocardial injury produced by global ischemia followed by reperfusion were tested and were further compared with those of quercetin and gallic acid, major antioxidative components of P. guajava L. and L. wrightii, respectively. Both extracts significantly attenuated ischemic contracture during ischemia and improved myocardial dysfunction after reperfusion. Decreases in high-energy phosphates and increases in malondialdehyde in the reperfused hearts were significantly lessened with both plant extracts. Quercetin and gallic acid also exerted similar beneficial effects. These results indicate that P. guajava L. and L. wrightii both have cardioprotective effects against myocardial ischemia-reperfusion injury in isolated rat hearts, primarily through their radical-scavenging actions.


Assuntos
Sequestradores de Radicais Livres/farmacologia , Traumatismo por Reperfusão Miocárdica/prevenção & controle , Fitoterapia , Plumbaginaceae , Psidium , Animais , Catalase/farmacologia , Ácido Gálico/farmacologia , Técnicas In Vitro , Japão , Masculino , Contração Miocárdica/efeitos dos fármacos , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Miocárdio/metabolismo , Extratos Vegetais/farmacologia , Folhas de Planta , Plumbaginaceae/química , Psidium/química , Quercetina/farmacologia , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/farmacologia , Fatores de Tempo , Função Ventricular Esquerda/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA